[DISCLOSURE]
Tego Science (191420) said on Sept. 21 that it has obtained a patent in Europe for transferring technology for stem cells in vivo.
The technology will be applied to developing skin and cartilage treatments based on regeneration of tissues.
By Jung Min-kyung (
mkj1105@heraldcorp.com)
